Business
Claritev Corporation Reports Third Quarter 2025 Results
MCLEAN, Va., November 07, 2025--Claritev Corporation Reports Third Quarter 2025 Results
About this update from Claritev Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1342,"height":250,"url":"https://media.zenfs.com/en/business-wire.com/574e925a96e72cf9d6803491d7576525"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gfEKGmCwJWO.cvrqVJJxCw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE3OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/574e925a96e72cf9d6803491d7576525","width":960,"height":179},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/xynaVN_OOh3.jXudlCPSdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/574e925a96e72cf9d6803491d7576525","width":1200,"height":224}},"lazy":false},{"type":"text","content":"– Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024","length":66,"tagName":"p"},{"type":"text","content":"– Net Loss of $69.8 million","length":27,"tagName":"p"},{"type":"text","content":"– Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024","length":70,"tagName":"p"},{"type":"text","content":"(Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024)","length":57,"tagName":"p","attribs":{}},{"type":"text","content":"– Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance","length":69,"tagName":"p"},{"type":"text","content":"MCLEAN, Va., November 07, 2025--(BUSINESS WIRE)--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025.","length":330,"tagName":"p"},{"type":"text","content":""We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that we have made the Turn and are now focused on the next phase of our Strategic Plan – The Way Up. We have laid the foundation for success, and continue to execute across our business, driving growth in our core solutions while delivering value across our expanded vertical and growing market segments. I am proud of how our team has embraced the clarity of our purpose to make healthcare affordable and transparent for all, and used that mission to continue building deeper relationships across the healthcare ecosystem,&qu...